Risk Profile Improvements

  • Material Weakness (improved) — Material weaknesses remain unremediated but remediation has advanced with implemented controls now in testing phase.
NASDAQ: AVR Anteris Technologies Global Corp. 10-Q

Anteris raises $320M, launches U.S. PARADIGM Trial, exits going-concern status

Filed May 12, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade AVR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.